About Animal Bioscience
Animal Bioscience is a private company based in Boston, Massachusetts. It has reported $4,653,528 raised in three offerings on Form D since September 2020. Its chief executive is Virginia Rentko.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Sep 9, 2026 | $2,320,000of $2.6M target | 15 | $154K | EquityRule 506(b) | Form D ↗ |
| Dec 23, 2021 | Jan 7, 2022 | $1,699,997of $4.0M target | 3 | $566K | EquityRule 506(b) | Form D ↗ |
| Sep 11, 2020 | Sep 25, 2020 | $633,531of $2.0M target | 2 | $316K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $4,653,528 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Animal Bioscience's Form D filed Sep 9, 2026.
Earlier filings also listed Brian Malone (director, last listed Sep 2020).